Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+42.4%
5Y CAGR+29.0%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+42.4%/yr
vs +92.2%/yr prior
5Y CAGR
+29.0%/yr
Recent acceleration
Acceleration
-49.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$1.74B+78.2%
2024$978.03M+69.9%
2023$575.76M-4.5%
2022$603.13M-0.5%
2021$605.90M+24.4%
2020$487.18M+317.5%
2019$116.70M+163.8%
2018$44.23M-